
Agree Realty Corporation (ADC)
$
70.81
+0.35 (0.49%)
Key metrics
Financial statements
Free cash flow per share
4.3515
Market cap
7.6 Billion
Price to sales ratio
11.0935
Debt to equity
0.5822
Current ratio
0.7052
Income quality
2.4940
Average inventory
0
ROE
0.0335
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. The company's stock is identified with the symbol 'ADC' in the market, reflecting its presence on the New York Stock Exchange. The company incurred an interest expense of $108,904,000.00 reflecting its debt servicing obligations, while the EBITDA is $543,265,000.00 a key indicator of the company's operational profitability. Additionally, the gross profit ratio is 0.88 highlighting the efficiency of the company's production and sales operations. The gross profit stands at $542,246,000.00 emphasizing the company’s profitability from core operations. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states, containing approximately 21.0 million square feet of gross leasable area, making it a significant player in the retail real estate sector. The stock is reasonably priced at $71.22 appealing to a broad range of investors. With an average trading volume of 1,168,393.00 the stock indicates moderate liquidity, allowing for active trading. The company, with a mid-range market capitalization of $7,639,481,586.00 is a steady performer in the market. It is a key player in the retail industry, contributing significantly to the overall market landscape, and it belongs to the Real Estate sector, driving innovation and growth. As such, Agree Realty Corporation plays an important role in the real estate investment trust segment, providing valuable investment opportunities while maintaining a robust portfolio of retail properties leased to reputable tenants.
Investing in Agree Realty Corporation (ADC) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Agree Realty Corporation stock to fluctuate between $67.58 (low) and $79.65 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-01-08, Agree Realty Corporation's market cap is $7,639,481,586, based on 107,887,044 outstanding shares.
Compared to PROLOGIS, INC., Agree Realty Corporation has a Lower Market-Cap, indicating a difference in performance.
Agree Realty Corporation pays dividends. The current dividend yield is 4.28%, with a payout of $0.26 per share.
To buy Agree Realty Corporation (ADC) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ADC. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Revenue: $617,095,000 | EPS: $1.79 | Growth: 5.29%.
Visit https://www.agreerealty.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $80.44 (2022-08-16) | All-time low: $52.69 (2023-10-30).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

prnewswire.com
LAUSANNE, Switzerland, Jan. 8, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that Ameet Mallik, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on Thursday, January 15, 2026, at 10:30 a.m.

businesswire.com
ROYAL OAK, Mich.--(BUSINESS WIRE)--Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced that it will release its fourth quarter and full year 2025 operating results after the market closes on Tuesday, February 10, 2026. A conference call to discuss the Company's operating results is scheduled for Wednesday, February 11, 2026, at 9:00 AM ET. Interested parties and shareholders may access the call via teleconference or webcast: Teleconference: USA Toll Free (800) 715-9871 Intern.

zacks.com
ADC deployed $1.55B in 2025 across 338 retail net lease properties, strengthening investment-grade rent and setting up $1.25B-$1.5B plans for 2026.

seekingalpha.com
Many REITs pay dividends on a monthly basis. Some offer up to 8% dividend yields. These are my favorite monthly-paying REITs.

prnewswire.com
LAUSANNE, Switzerland, Jan. 2, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that the Company has made a grant of options to purchase an aggregate of 6,000 of the Company's common shares to a new employee on January 2, 2026 ("Grant"). The Grant was offered as material inducement to the employee's employment.

seekingalpha.com
I present a 20-stock model retirement portfolio targeting a balanced 5.6% yield, emphasizing both income and dividend growth. My approach avoids "sucker yields" by focusing on quality, sustainable payouts rather than chasing unsustainable high-yield stocks. The portfolio is diversified across BDCs, REITs, energy, and growth names, with allocations reflecting risk, yield, and income stability.

prnewswire.com
NEW YORK, Jan. 1, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC Therapeutics" or the "Company") (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

globenewswire.com
NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC Therapeutics” or the “Company”) (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

fool.com
ExxonMobil has increased its dividend payment for 43 years in a row. Agree Realty has grown its dividend at a 5.3% compound annual rate over the last 10 years.

247wallst.com
While reaching retirement age can be both a blessing and a curse, relying on the U.S.
See all news